NCT02154087View on ClinicalTrials.gov

A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers

PHASE2TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions

Venous Leg Ulcers

Interventions

BIOLOGICAL

HP802-247

260 µL (130 µL, one spray, of each component) containing 0.5 x 10.6 cells per mL, alternating weekly with Vehicle

Trial Locations (1)

42305

Columbus

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Healthpoint

INDUSTRY